Plain-English translation of NCT06898814 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether a single intravenous iron infusion called can help elderly patients recover their mobility and walking ability after hip fracture surgery. Low iron levels (anemia) are common after surgery and can make recovery slower and cause fatigue. Researchers hope this medication will help restore iron levels, boost energy, and help patients regain their independence.
After hip fracture surgery, many elderly patients develop anemia (low iron), which can slow their recovery and make them feel very tired. This trial exists to see whether treating low iron early with this medication can help patients regain their walking ability and strength faster.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either one iron infusion or a placebo (saline) within one to five days after your hip fracture surgery. The infusion is given intravenously (through an IV) as a single dose. After that, you will be followed over weeks and months so researchers can measure how well you regain your walking ability and mobility compared to before your fracture.
AI-generated summary from trial data · Sep 24, 2026 · Not medical advice
Denmark